Factor VIII-Related Activities in Normal, Haemophilic and von Willebrand’s Disease Platelet Fractions

Summary

Factor VIII-related activities have been studied in platelet fractions in order to try to reconcile the conflicting findings of other workers, and to extend the studies. In platelets from 16 normal subjects procoagulant factor VIII was not detected. The amount of factor VIII-related antigen (FVIIIR: AG) in the cytosol per mg of protein was about twice that in the membrane fraction and about ten times that in the debris fraction. There was no significant difference between the amount of FVIIIR: AG and ristocetin cofactor (RistCof) activity in each fraction. The findings in haemophilic platelets were similar. In von Willebrand’s disease (vWd) one serverely affected patient had no detectable factor VIII related activities in any platelet fraction. In 5 patients with intermediate vWd results were normal. In a further 5, with more prolonged bleeding times, no FVIIIR: RistCof was detected in platelets, despite a normal amount of FVIIIR: AG in the cytosol and debris. The electrophoretic mobility of cytosol FVIIIR: AG was increased in all normals and patients, while that in the membrane and debris fractions had normal mobility. Cytosol FVIIIR: AG eluted later than normal FVIIIR: AG on gel filtration on Sepharose 2B, and also showed reduced antibody binding in an immunoradiometric assay. Precipitation of FVIIIR: AG by concanavalin A was incomplete in all platelet fractions from normals, and even more reduced in vWd platelet fractions. The results suggest the possibility of two types of platelet FVIIIR: AG.

A factor VIII-related antigen was shown to be associated with normal washed platelets by immunofluorescence techniques (Bloom et al. 1973). Since then, several studies have been reported on the localisation of factor VIII related antigen (FVIIIR: AG), factor VIII procoagulant activity (FVIII: C) and factor VIII related ristocetin cofactor activity (FVIIIR: RistCof) within the platelets. Initially, Howard et al. (1974) indicated that FVIIIR: AG was firmly bound to the platelet membrane, and noted that in lysed platelets the level of FVIIIR: AG as measured by electroimmunodiffusion was higher than that in whole platelet suspensions. However, further studies by Nachman and Jaffe (1975) showed that FVIIIR: AG was also present to a considerable extent in the granules, and they detected none in the platelet cytosol. Bouma and colleagues (1975) were, however, able to find FVIIIR: AG and FVIIIR: RistCof in the cytosol upon freezing and thawing platelets. This FVIIIR: AG had an electrophoretic mobility comparable to that of normal plasma. They also noted that platelets which were air dried apparently had a granular FVIIIR:AG localisation by immunfluorescence; however, intact platelets in suspension did not stain by this method.

Recently Ruggeri et al. (1977) and Sultan et al. (1977) have also found FVIIIR: AG in the cytosol, and the former authors reported it to have increased electrophoretic mobility when compared to normal plasma FVIIIR:AG. Results concerning the localisation of FVIIIR: AG in normal platelets have thus been conflicting. Similarly, in the few reports available concerning platelet FVIIIR: AG in von Willibrand’s disease variable results have also been obtained (Ruggeri et al. 1977, Howard et al. 1974, Shearn et al. 1974 and Bouma et al. 1975).

In this study we report on the localisation of factor VIII-related activities in normal, haemophilic and von Willebrand’s disease platelets using available standard techniques as well as precipitation of FVIIIR: AG with the plant lectin concanavalin A, a procedure which has been shown to detect abnormal forms of FVIIIR:AG in certain types of von Willebrand’s disease (Peake and Bloom 1977).

• References

• 1 Barber AJ, Jamieson GA. 1970; Isolation and characterisation of plasma membranes from human blood platelets. Journal of Biological Chemistry 245: 6357
• 2 Bloom AL, Giddings JC, Wilks CJ. 1973; Factor VIII on the vascular intima: possible importance in haemostasis an thrombosis. Nature New Biology 241: 217
• 3 Bloom AL, Peake IR, Giddings JC. 1973; The presence and reactions of high and lower molecular weight prcoagulant factor VIII in the plasma of patients with von Willebrand’s disease after treatment: significance for a structural hypothesis for factor VIII. Thrombosis Research 3: 389
• 4 Bouma BN, Horduk-Hos JM, De Graaf S, Sixma JJ. 1975; Presence of factor VIII- related antigen in blood platelets of patients with von Willebrand’s disease. Nature 257: 510
• 5 Howard MA, Montgomery DC, Hardisty RM. 1974; Factor VIII related antigen in platelets. Thrombosis Research 4: 617
• 6 Ivy AC, Nelson D, Bucher G. 1941; The standarisation of certain factors in the cutaneous »hemostasis« bleeding time technique. Journal of Laboratory and Clinical Medicine 26: 1812
• 7 Jaffe EA, Hoyer LW, Nachman RL. 1973; Synthesis of antihemophilic factor antigen by cultured human endothelial cells. Journal of Clinical Investigation 52: 2151
• 8 Jaffe EA, Hoyer LW, Nachman RL. 1974; Synthesis of von Willebrand factor by cultured human endothelial cells. Proceedings of National Academy of Sciences, USA 71: 1906
• 9 Jaffe EA. 1977; Endothelial cells and the biology of factor VIII. New England Journal of Medicine 296: 377
• 10 Kass L, Ratnoff OD, Leon MA. 1969; Studies on the purification of antihemophilic factor (factor VIII). Precipitation of antihemophilic factor by Coneanavalin A Journal of Clinical Investigation 48: 351
• 11 Laurell CB. 1966; Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 15: 45
• 12 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951; Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193: 265
• 13 Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, Mcpherson J. 1975; A method for assaying von Willebrand factor (ristocetin cofactor). Thrombosis et Diathesis Haemorrhagica 34: 306
• 14 Nachman RL, Jaffe EA. 1975; Subcellular platelet factor VIII antigen and von Willebrand factor. Journal of Experimental Medicine 141: 1101
• 15 Nachman RL, Levine R, Jaffe EA. 1977; Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. Journal of Clinical Investigation 60: 914
• 16 Peake IR, Bloom AL, Giddings JC. 1974; Inherited variants of factor VIII related protein in von Willebrand’s disease. New England Journal of Medicine 291: 113
• 17 Peake IR, Bloom AL. 1977; a The use of an immunoradiometric assay for factor VIII related antigen in the study of atypical von Willebrand’s disease. Thrombosis Research 10: 27
• 18 Peake IR, Bloom AL. 1977; b Abnormal factor VIII related antigen (FVIIIR:AG) in von Willebrand’s disease (vWd): Decreased precipitation by Coneanavalin A. Thrombosis and Haemostasis 37: 361
• 19 Pool JG, Robinson J. 1959; Assay of plasma antihaemophilic globulin. British Journal of Haematology 5: 17
• 20 Ruggeri ZM, Mannucci PM, Bader R, Barbui T. Factor VIII related properties in platelets from patients with von Willebrand’s disease. Journal of Laboratory and Clinical Medicine (in press).
• 22 Shearn SA M, Giddings JC, Peake IR, Bloom AL. 1974; A comparison of five different rabbit antisera to factor VIII and the demonstration of factor VIII related antigen in normal and von Willebrand’s disease platelets. Thrombosis Research 5: 585
• 22 Shearn SA M, Peake IR, Giddings JC, Humphrys J, Bloom AL. 1977; The characterisation and synthesis of antigens related to factor VIII in vascular endothelium. Thrombosis Research II: 43
• 23 Sultan T, Bouma BN, De Graaf S, Simeon J, Caen JP, Sixma JJ. 1977; Factor VIII related antigen in platelets of patients with von Willebrand’s disease. Thrombosis Research II: 23